ImmunityBio, Inc.
IBRX
$8.56
$0.354.26%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 242.82M | 257.81M | 153.66M | 61.59M | 149.81M |
| Total Receivables | 42.62M | 33.72M | 22.33M | 17.45M | 2.65M |
| Inventory | 910.00K | 6.70M | 6.64M | 8.44M | 8.27M |
| Prepaid Expenses | 16.85M | 19.02M | 15.85M | 13.62M | 16.73M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.68M | 12.25M | 9.65M | 8.05M | 7.12M |
| Total Current Assets | 314.88M | 329.50M | 208.13M | 109.16M | 184.59M |
|
|
|||||
| Total Current Assets | 314.88M | 329.50M | 208.13M | 109.16M | 184.59M |
| Net Property, Plant & Equipment | 147.55M | 163.08M | 168.03M | 167.05M | 170.46M |
| Long-term Investments | 910.00K | 910.00K | 910.00K | 910.00K | 910.00K |
| Goodwill | 910.00K | 910.00K | 910.00K | 910.00K | 910.00K |
| Total Other Intangibles | 13.04M | 13.57M | 14.07M | 14.53M | 15.02M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.32M | 11.24M | 10.24M | 11.40M | 11.26M |
| Total Assets | 501.90M | 518.99M | 402.08M | 303.76M | 382.93M |
|
|
|||||
| Total Accounts Payable | 6.98M | 5.77M | 7.42M | 13.50M | 6.73M |
| Total Accrued Expenses | 42.01M | 39.33M | 33.89M | 25.59M | 38.28M |
| Short-term Debt | 1.75M | 2.60M | -- | -- | 1.25M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.59M | 7.37M | 7.44M | 7.46M | 7.47M |
| Total Finance Division Other Current Liabilities | 3.42M | 2.07M | 1.90M | 2.66M | 1.22M |
| Total Other Current Liabilities | 3.42M | 2.07M | 1.90M | 2.66M | 1.22M |
| Total Current Liabilities | 61.75M | 57.13M | 50.64M | 49.21M | 54.94M |
|
|
|||||
| Total Current Liabilities | 61.75M | 57.13M | 50.64M | 49.21M | 54.94M |
| Long-Term Debt | 801.71M | 816.95M | 799.13M | 782.00M | 746.28M |
| Short-term Debt | 1.75M | 2.60M | -- | -- | 1.25M |
| Capital Leases | 33.67M | 34.37M | 36.09M | 33.10M | 34.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 104.34M | 133.94M | 86.03M | 29.94M | 35.01M |
| Total Liabilities | 1.00B | 1.04B | 971.90M | 894.24M | 871.06M |
|
|
|||||
| Common Stock & APIC | 3.20B | 3.14B | 3.01B | 2.89B | 2.88B |
| Retained Earnings | -3.73B | -3.66B | -3.60B | -3.50B | -3.38B |
| Treasury Stock & Other | 28.96M | 5.00M | 12.57M | 19.96M | 1.20M |
| Total Common Equity | -500.47M | -524.32M | -570.75M | -591.43M | -489.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -500.47M | -524.32M | -570.75M | -591.43M | -489.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 895.00K | 909.00K | 930.00K | 949.00K | 969.00K |
| Total Equity | -499.57M | -523.41M | -569.82M | -590.48M | -488.13M |
|
|
|||||